BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15341067)

  • 1. [Comparative assessment of cell mechanisms of the antidiabetic action of a new organic derivative of oxovanadium(IV) and vanadyl sulfate].
    Aleeva GN; Kiiasov AP; Burykin IM; Khafiz'ianova RKh
    Eksp Klin Farmakol; 2004; 67(3):42-4. PubMed ID: 15341067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats.
    Bolkent S; Bolkent S; Yanardag R; Tunali S
    Diabetes Res Clin Pract; 2005 Nov; 70(2):103-9. PubMed ID: 16188572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new orally active antidiabetic vanadyl complex--bis(alpha-furancarboxylato)oxovanadium(IV).
    Xie M; Gao L; Li L; Liu W; Yan S
    J Inorg Biochem; 2005 Feb; 99(2):546-51. PubMed ID: 15621288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
    Yuen VG; Orvig C; McNeill JH
    Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
    Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
    Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
    Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
    J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vanadyl ion suppresses nitric oxide production from peritoneal macrophages of streptozotocin-induced diabetic mice.
    Tsuji A; Sakurai H
    Biochem Biophys Res Commun; 1996 Sep; 226(2):506-11. PubMed ID: 8806664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.
    Liboiron BD; Thompson KH; Hanson GR; Lam E; Aebischer N; Orvig C
    J Am Chem Soc; 2005 Apr; 127(14):5104-15. PubMed ID: 15810845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-enhancing activity of a dinuclear vanadium complex: 5-chloro-salicylaldhyde ethylenediamine oxovanadium(V) and its permeability and cytotoxicity.
    Xie MJ; Yang XD; Liu WP; Yan SP; Meng ZH
    J Inorg Biochem; 2010 Aug; 104(8):851-7. PubMed ID: 20434776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vanadium compounds as insulin mimics.
    Orvig C; Thompson KH; Battell M; McNeill JH
    Met Ions Biol Syst; 1995; 31():575-94. PubMed ID: 8564818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of vanadyl sulfate on kidney in experimental diabetes.
    Yanardag R; Bolkent S; Karabulut-Bulan O; Tunali S
    Biol Trace Elem Res; 2003 Oct; 95(1):73-85. PubMed ID: 14555801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate.
    Willsky GR; Chi LH; Liang Y; Gaile DP; Hu Z; Crans DC
    Physiol Genomics; 2006 Aug; 26(3):192-201. PubMed ID: 16684804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of a new vanadium compound, bis(2,2'-bipyridine)oxovanadium(IV) sulphate on liver golgi complexes from control and streptozotocin-diabetic rats.
    Kordowiak AM; DabroĊ› W; Kajda B
    Horm Metab Res; 2002 Oct; 34(10):556-60. PubMed ID: 12439783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vanadyl sulfate ameliorates insulin resistance and restores plasma dehydroepiandrosterone-sulfate levels in fructose-fed, insulin-resistant rats.
    Harati M; Ani M
    Clin Biochem; 2004 Aug; 37(8):694-7. PubMed ID: 15302613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new insulin-mimetic vanadyl complex, (N-pyridylmethylaspartate)oxovanadium(IV) with VO(N2O2) coordination mode, and evaluation of its effect on uptake of D-glucose by Ehrlich ascites tumour cells.
    Tawa R; Uchida K; Taniyama J; Fujisawa Y; Fujimoto S; Nagaoka T; Kanamori K; Sakurai H
    J Pharm Pharmacol; 1999 Feb; 51(2):119-24. PubMed ID: 10217308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vanadyl sulfate on liver of streptozotocin-induced diabetic rats.
    Koyuturk M; Tunali S; Bolkent S; Yanardag R
    Biol Trace Elem Res; 2005 Jun; 104(3):233-47. PubMed ID: 15930593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordination chemistry and insulin-enhancing behavior of vanadium complexes with maltol C6H6O3 structural isomers.
    Saatchi K; Thompson KH; Patrick BO; Pink M; Yuen VG; McNeill JH; Orvig C
    Inorg Chem; 2005 Apr; 44(8):2689-97. PubMed ID: 15819554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanadium (vanadyl sulfate). Monograph.
    Altern Med Rev; 2009 Jun; 14(2):177-80. PubMed ID: 19594227
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis, spectroscopic, structural and thermal characterizations of vanadyl(IV) adenine complex prospective as antidiabetic drug agent.
    El-Megharbel SM; Hamza RZ; Refat MS
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():850-64. PubMed ID: 25150436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calorimetric studies of the interaction between the insulin-enhancing drug candidate bis(maltolato)oxovanadium(IV) (BMOV) and human serum apo-transferrin.
    Bordbar AK; Creagh AL; Mohammadi F; Haynes CA; Orvig C
    J Inorg Biochem; 2009 Apr; 103(4):643-7. PubMed ID: 19056126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.